• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 L3-I148M 变异通过诱导线粒体功能障碍促进肝纤维化的进展。

PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction.

机构信息

The Third Unit, The Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.

Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.

出版信息

Int J Mol Sci. 2023 Jun 2;24(11):9681. doi: 10.3390/ijms24119681.

DOI:10.3390/ijms24119681
PMID:37298640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10253263/
Abstract

Patatin-like phospholipase domain-containing 3 (PNPLA3) rs738409 polymorphism (I148M) is strongly associated with non-alcoholic steatohepatitis and advanced fibrosis; however, the underlying mechanisms remain largely unknown. In this study, we investigated the effect of PNPLA3-I148M on the activation of hepatic stellate cell line LX-2 and the progression of liver fibrosis. Immunofluorescence staining and enzyme-linked immunosorbent assay were used to detect lipid accumulation. The expression levels of fibrosis, cholesterol metabolism, and mitochondria-related markers were measured via real-time PCR or western blotting. Electron microscopy was applied to analyze the ultrastructure of the mitochondria. Mitochondrial respiration was measured by a Seahorse XFe96 analyzer. PNPLA3-I148M significantly promoted intracellular free cholesterol aggregation in LX-2 cells by decreasing cholesterol efflux protein (ABCG1) expression; it subsequently induced mitochondrial dysfunction characterized by attenuated ATP production and mitochondrial membrane potential, elevated ROS levels, caused mitochondrial structural damage, altered the oxygen consumption rate, and decreased the expression of mitochondrial-function-related proteins. Our results demonstrated for the first time that PNPLA3-I148M causes mitochondrial dysfunction of LX-2 cells through the accumulation of free cholesterol, thereby promoting the activation of LX-2 cells and the development of liver fibrosis.

摘要

载脂蛋白样磷脂酶域蛋白 3(PNPLA3)rs738409 多态性(I148M)与非酒精性脂肪性肝炎和肝纤维化进展密切相关;然而,其潜在机制在很大程度上仍不清楚。在这项研究中,我们研究了 PNPLA3-I148M 对肝星状细胞系 LX-2 激活和肝纤维化进展的影响。免疫荧光染色和酶联免疫吸附试验用于检测脂质积累。通过实时 PCR 或 Western blot 测量纤维化、胆固醇代谢和线粒体相关标志物的表达水平。电子显微镜用于分析线粒体的超微结构。通过 Seahorse XFe96 分析仪测量线粒体呼吸。PNPLA3-I148M 通过降低胆固醇外排蛋白(ABCG1)的表达,显著促进 LX-2 细胞内游离胆固醇聚集,随后诱导线粒体功能障碍,表现为 ATP 产生和线粒体膜电位减弱、ROS 水平升高、线粒体结构损伤、耗氧率改变以及线粒体功能相关蛋白表达降低。我们的研究结果首次表明,PNPLA3-I148M 通过游离胆固醇的积累导致 LX-2 细胞的线粒体功能障碍,从而促进 LX-2 细胞的激活和肝纤维化的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/c595b094a90e/ijms-24-09681-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/ebbf69a556c1/ijms-24-09681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/802b4f766469/ijms-24-09681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/6f9925325a01/ijms-24-09681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/00c9a1715e23/ijms-24-09681-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/b0761534cc25/ijms-24-09681-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/c595b094a90e/ijms-24-09681-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/ebbf69a556c1/ijms-24-09681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/802b4f766469/ijms-24-09681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/6f9925325a01/ijms-24-09681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/00c9a1715e23/ijms-24-09681-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/b0761534cc25/ijms-24-09681-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0643/10253263/c595b094a90e/ijms-24-09681-g006.jpg

相似文献

1
PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction.载脂蛋白 L3-I148M 变异通过诱导线粒体功能障碍促进肝纤维化的进展。
Int J Mol Sci. 2023 Jun 2;24(11):9681. doi: 10.3390/ijms24119681.
2
PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.非酒精性脂肪性肝病中的PNPLA3 I148M变异:人口统计学和种族特征以及该变异在非酒精性脂肪性肝纤维化中的作用
World J Gastroenterol. 2015 Jan 21;21(3):794-802. doi: 10.3748/wjg.v21.i3.794.
3
The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.载脂蛋白 L3 基因 I148M 变异可调节人肝星状细胞的纤维生成表型。
Hepatology. 2017 Jun;65(6):1875-1890. doi: 10.1002/hep.29041. Epub 2017 Apr 18.
4
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis.鉴定载脂蛋白样磷脂酶结构域蛋白 3 介导的脂肪性肝炎加速的代谢组学、转录组学和分子特征。
Hepatology. 2021 Apr;73(4):1290-1306. doi: 10.1002/hep.31609. Epub 2021 Mar 19.
5
PNPLA3 I148M polymorphism and progressive liver disease.PNPLA3 I148M 多态性与进行性肝病。
World J Gastroenterol. 2013 Nov 7;19(41):6969-78. doi: 10.3748/wjg.v19.i41.6969.
6
Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.利用 3D 细胞外基质模型探索 PNPLA3 I148M 变异对原代人肝星状细胞的影响。
J Hepatol. 2024 Jun;80(6):941-956. doi: 10.1016/j.jhep.2024.01.032. Epub 2024 Feb 15.
7
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.载脂蛋白样磷脂酶结构域蛋白 3 基因 I148M 多态性与遗传性血色素沉着症中的脂肪变性和肝损伤。
World J Gastroenterol. 2012 Jun 14;18(22):2813-20. doi: 10.3748/wjg.v18.i22.2813.
8
Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype.非酒精性脂肪性肝病患者载脂蛋白基因 I148M GG 基因型与肝外癌症及肝纤维化的相关性。
Cancer Sci. 2024 Feb;115(2):564-574. doi: 10.1111/cas.16042. Epub 2023 Dec 11.
9
The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.rs2294918 E434K 变体调节脂肪酶结构域包含蛋白 3 的表达并导致肝损伤。
Hepatology. 2016 Mar;63(3):787-98. doi: 10.1002/hep.28370. Epub 2016 Jan 14.
10
Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals.长期高卡路里饮食会加重 PNPLA3 I148M 动物的代谢性肝病。
Liver Int. 2023 Aug;43(8):1699-1713. doi: 10.1111/liv.15587. Epub 2023 Apr 18.

引用本文的文献

1
Integrated Patient Digital and Biomimetic Twins for Precision Medicine: A Perspective.用于精准医学的综合患者数字双胞胎和仿生双胞胎:一种观点
Semin Liver Dis. 2025 Jul 23. doi: 10.1055/a-2649-1560.
2
Experimental Models to Investigate PNPLA3 in Liver Steatosis.用于研究PNPLA3在肝脂肪变性中作用的实验模型。
Liver Int. 2025 May;45(5):e70091. doi: 10.1111/liv.70091.
3
Aging, ROS, and cellular senescence: a trilogy in the progression of liver fibrosis.衰老、ROS 和细胞衰老:肝纤维化进展中的三部曲。

本文引用的文献

1
Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.载脂蛋白基因 PNPLA3 I148M 变异、饮酒和肥胖与肝硬化、肝细胞癌和死亡风险的协同关联。
JAMA Netw Open. 2022 Oct 3;5(10):e2234221. doi: 10.1001/jamanetworkopen.2022.34221.
2
Oxidative stress-mediated mitochondrial fission promotes hepatic stellate cell activation via stimulating oxidative phosphorylation.氧化应激介导的线粒体裂变通过刺激氧化磷酸化促进肝星状细胞活化。
Cell Death Dis. 2022 Aug 6;13(8):689. doi: 10.1038/s41419-022-05088-x.
3
ABCA1, ABCG1, and Cholesterol Homeostasis.
Biogerontology. 2024 Nov 15;26(1):10. doi: 10.1007/s10522-024-10153-3.
4
Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk.PNPLA3在肝星状细胞及肝细胞相互作用中的作用
Liver Int. 2025 Apr;45(4):e16117. doi: 10.1111/liv.16117. Epub 2024 Oct 12.
5
Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy.在用于代谢功能障碍相关脂肪性肝病精准治疗的人源化肝脏微生理系统中野生型和高危PNPLA3变体的比较
Front Cell Dev Biol. 2024 Sep 11;12:1423936. doi: 10.3389/fcell.2024.1423936. eCollection 2024.
6
Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants.即使存在PNPLA3变体,胰岛素抵抗仍是代谢相关脂肪性肝病的一个固有特征。
JHEP Rep. 2024 Apr 6;6(7):101092. doi: 10.1016/j.jhepr.2024.101092. eCollection 2024 Jul.
7
In Vitro Lipid Overload Affects Cellular Proliferation, Apoptosis, and Senescence in a Time-Dependent Manner in HepG2 Hepatocytes and LX-2 Hepatic Stellate Cells.在体脂质过载以时间依赖的方式影响 HepG2 肝细胞和 LX-2 肝星状细胞的细胞增殖、凋亡和衰老。
Cells. 2024 Feb 4;13(3):282. doi: 10.3390/cells13030282.
ABCA1、ABCG1 和胆固醇稳态。
Adv Exp Med Biol. 2022;1377:95-107. doi: 10.1007/978-981-19-1592-5_7.
4
SOD1 mediates lysosome-to-mitochondria communication and its dysregulation by amyloid-β oligomers.SOD1 介导溶酶体到线粒体的通讯及其由淀粉样β寡聚物引起的失调。
Neurobiol Dis. 2022 Jul;169:105737. doi: 10.1016/j.nbd.2022.105737. Epub 2022 Apr 20.
5
Cholesterol Induces Oxidative Stress, Mitochondrial Damage and Death in Hepatic Stellate Cells to Mitigate Liver Fibrosis in Mice Model of NASH.胆固醇在非酒精性脂肪性肝炎小鼠模型中诱导肝星状细胞发生氧化应激、线粒体损伤和死亡,以减轻肝纤维化。
Antioxidants (Basel). 2022 Mar 11;11(3):536. doi: 10.3390/antiox11030536.
6
Hepatic stellate cells in physiology and pathology.肝星状细胞的生理与病理。
J Physiol. 2022 Apr;600(8):1825-1837. doi: 10.1113/JP281061. Epub 2022 Mar 30.
7
Molecular mechanisms for ABCA1-mediated cholesterol efflux.ABCA1 介导的胆固醇外流的分子机制。
Cell Cycle. 2022 Jun;21(11):1121-1139. doi: 10.1080/15384101.2022.2042777. Epub 2022 Feb 22.
8
PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date.PNPLA3 作为脂肪性肝病的治疗靶点:现有证据。
Expert Opin Ther Targets. 2021 Dec;25(12):1033-1043. doi: 10.1080/14728222.2021.2018418. Epub 2021 Dec 22.
9
Hepatic Stellate Cell: A Double-Edged Sword in the Liver.肝星状细胞:肝脏中的双刃剑。
Physiol Res. 2021 Dec 30;70(6):821-829. doi: 10.33549/physiolres.934755. Epub 2021 Oct 30.
10
Role of Cholesterol-Associated Steatohepatitis in the Development of NASH.胆固醇相关性脂肪性肝炎在 NASH 发展中的作用。
Hepatol Commun. 2022 Jan;6(1):12-35. doi: 10.1002/hep4.1801. Epub 2021 Aug 24.